Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan-Reference-Cited by-同舟云学术

Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan

Published:2020-10-01 Issue:19-20 Volume:31 Page:1043-1053
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Yamaguchi Teruhide¹²,Uchida Eriko³,Okada Takashi⁴,Ozawa Keiya⁵,Onodera Masafumi⁶,Kume Akihiro⁵,Shimada Takashi⁷,Takahashi Satoru⁸,Tani Kenzaburo⁴,Nasu Yasutomo⁹,Mashimo Tomoji⁴,Mizuguchi Hiroyuki¹⁰,Mitani Kohnosuke¹¹,Maki Kazushige¹²

Affiliation:

1. Kanazawa Institute of Technology, Ishikawa, Japan

2. Nihon Pharmaceutical University;

3. National Institute of Health Sciences;

4. The University of Tokyo;

5. Jichi Medical University;

6. National Center for Child Health and Development;

7. Nippon Medical School;

8. University of Tsukuba;

9. Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

10. Osaka University;

11. Saitama Medical University;

12. Pharmaceuticals and Medical Devices Agency.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2020.156

Reference69 articles.

1. TAL Effectors: Customizable Proteins for DNA Targeting

2. RNA-Guided Human Genome Engineering via Cas9

3. Genome Engineering With Zinc-Finger Nucleases

4. The double-strand-break repair model for recombination

5. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAV-based in vivo gene therapy for neurological disorders;Nature Reviews Drug Discovery;2023-09-01

2. Current trends and risks associated with the use of therapies based on genome editing;Biological Products. Prevention, Diagnosis, Treatment;2023-07-27

3. Gene Therapy of Extracellular Vesicles in Cardiovascular and Metabolic Diseases;Advances in Experimental Medicine and Biology;2023

4. Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective;Advances in Experimental Medicine and Biology;2023

5. Contiguous Governance of Synchronic and Diachronic Changes for the Use of Genome Editing Technologies;Frontiers in Political Science;2022-02-25